Drug-coated vs non-drug-coated devices for femoropopliteal artery interventions: long-term outcomes of the SAFE-PAD study
In this final report from the SAFE-PAD study, there was no evidence of long-term mortality risk associated with DCDs used for femoropopliteal revascularization. The SAFE-PAD study helped inform the reversal of regulatory warnings against routine DCD use.
Authors
- Eric A. Secemsky (ORCID: https://orcid.org/0000-0003-3861-3163)
- Robert W. Yeh (ORCID: https://orcid.org/0000-0002-0564-4468)
- Yang Song (ORCID: https://orcid.org/0000-0002-3544-0183)
- Joseph M. Kim (ORCID: https://orcid.org/0000-0003-1584-3927)
Institutions
- Deaconess Hospital (US)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1093/eurheartj/ehaf721
- Citations
- 3
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 6.02